Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
61 studies found for:    leukemia AND portland | United States, Oregon | Phase 2 | NIH
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: azacitidine;   Drug: gemtuzumab ozogamicin
2 Active, not recruiting Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Previously Treated Myelodysplastic Syndrome;   Refractory Anemia With Excess Blasts;   Secondary Myelodysplastic Syndrome
Interventions: Drug: Azacitidine;   Drug: Lenalidomide;   Drug: Vorinostat
3 Completed S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: cytarabine;   Drug: gemtuzumab ozogamicin
4 Completed 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia;   Lymphoma
Intervention: Drug: nelarabine
5 Completed S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
Condition: Leukemia
Intervention: Drug: nelarabine
6 Completed SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
Conditions: Leukemia;   Neutropenia;   Thrombocytopenia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Radiation: radiation therapy
7 Completed S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: cytarabine;   Drug: daunorubicin hydrochloride
8 Completed S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: valspodar
9 Active, not recruiting Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Childhood Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Lymphoblastic Lymphoma;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase;   Drug: doxorubicin hydrochloride;   Drug: therapeutic hydrocortisone;   Drug: liposomal vincristine sulfate;   Drug: cytarabine;   Drug: prednisone;   Drug: bortezomib;   Drug: pegaspargase;   Drug: methotrexate;   Drug: etoposide phosphate;   Drug: cyclophosphamide;   Biological: filgrastim;   Drug: leucovorin calcium;   Other: laboratory biomarker analysis
10 Completed Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Childhood Hepatoblastoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Malignant Germ Cell Tumor;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Interventions: Drug: alisertib;   Other: pharmacological study;   Other: laboratory biomarker analysis
11 Completed Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
Condition: Leukemia
Intervention: Drug: docetaxel
12 Active, not recruiting
Has Results
Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Chronic Phase Chronic Myelogenous Leukemia
Interventions: Drug: dasatinib;   Drug: imatinib mesylate;   Other: laboratory biomarker analysis
13 Completed Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Condition: Leukemia
Intervention: Drug: gemcitabine hydrochloride
14 Completed Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: cladribine;   Drug: idarubicin
15 Completed Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: doxorubicin hydrochloride;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: pegaspargase;   Drug: thioguanine;   Drug: vincristine sulfate;   Procedure: allogeneic bone marrow transplantation;   Radiation: radiation therapy
16 Terminated
Has Results
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Biological: therapeutic allogeneic lymphocytes;   Drug: cyclosporine;   Drug: fludarabine;   Drug: mycophenolate mofetil;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
17 Recruiting Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
Conditions: Childhood B Acute Lymphoblastic Leukemia;   Childhood Burkitt Leukemia;   Childhood Diffuse Large Cell Lymphoma;   Mediastinal (Thymic) Large B-Cell Lymphoma;   Stage III Childhood Large Cell Lymphoma;   Stage IV Childhood Large Cell Lymphoma
Interventions: Biological: Rituximab;   Drug: Prednisone;   Drug: Etoposide;   Drug: Doxorubicin Hydrochloride;   Drug: Cytarabine;   Drug: Vincristine Sulfate;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Leucovorin Calcium;   Drug: Therapeutic Hydrocortisone;   Other: Laboratory Biomarker Analysis
18 Recruiting Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
Conditions: Acute Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplasia;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Lymphoma, B-Cell;   Lymphoma, Follicular;   Lymphoma, Large B-Cell, Diffuse
Interventions: Drug: Tacrolimus (ARM with Methotrexate);   Drug: Tacrolimus (ARM with MMF and Cyclophosphamide);   Drug: Methotrexate (ARM with Maraviroc);   Drug: Methotrexate (ARM with Bortezomib);   Drug: Maraviroc;   Drug: Bortezomib;   Drug: Mycophenolate mofetil;   Drug: Cyclophosphamide
19 Completed S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclosporine
20 Completed Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: asparaginase;   Drug: cyclophosphamide;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: liposomal cytarabine;   Drug: mercaptopurine;   Drug: mesna;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: thiotepa;   Drug: vincristine sulfate;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years